Videos
Videos
LATEST VIDEOS
Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments
PRESENTED BY
Dr. Tony Sanchez and Josh Wemmer from Invivoscribe, Inc.
The Evolving Role of NGS and Measurable Residual Disease in CLL/SLL and AML
PRESENTED BY
Dr. Bevan Tandon, Chief Medical Officer of siParadigm Diagnostics Informatics and Dr. Jason Willis, Lead Hematopathologist of LabPMM (a wholly-owned subsidiary of Invivoscribe) at the AMP 2023 Annual Meeting & Expo
MRD Applications and Analysis
PRESENTED BY
Dr. Linda Lee from Royal North Shore Hospital and Dr. Irene Della Starza from Fondazione GIMEMA Franco Mandelli Onlus and Sapienza University, Rome
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms and Primers
PRESENTED BY
Kseniya Petrova-Drus M.D., PhD from Memorial Sloan Kettering Cancer Center
Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring
PRESENTED BY
Joseph Annunziata, M.D. from Kindred Healthcare
